据报道,服用卡维地洛的患者新发糖尿病的可能性比服用美托洛尔者低22%。
Patients taking carvedilol were 22% less likely to develop new onset diabetes than patients taking metoprolol, the authors report.
移植后新发糖尿病(NODAT)是一种器官移植前无糖尿病病史而移植术后新发生的继发性糖尿病,发病率较高。
New-Onset diabetes mellitus after transplantation(NODAT) is a significant complication after transplantation and has shown an increasing incidence in recent years.
现在已经很清楚,新发糖尿病和糖尿病前期状态(空腹血糖受损和糖耐量受损)的负面影响移植后的移植物和患者的生存。
It has become clear that both new-onset diabetes and prediabetic states (impaired fasting glucose and impaired glucose tolerance) negatively influence graft and patient survival after transplantation.
应用推荐